(FM) Medicina Interna
Departamento académico
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas Southwestern Medical Center (8)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
-
Evidence and choice: The BCLC vision for tailoring clinical decision-making
Journal of Hepatology
-
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis
Journal of Hepatology
2022
-
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Journal of Hepatology, Vol. 76, Núm. 3, pp. 681-693
2021
-
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC
Hepatology Communications, Vol. 5, Núm. 3, pp. 538-547
2020
-
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1
2019
-
A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets
Journal of Hepatology, Vol. 71, Núm. 1, pp. 78-90